(Q45874869)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15103320%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15103320%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15103320%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Karl Ljungberg

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15103320%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

José Arteaga

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15103320%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

7

Britta Wahren

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15103320%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

E Rollman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15103320%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

B Zuber

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15103320%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

A Kjerrström

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15103320%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

M Liu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15103320%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 July 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15103320%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15103320%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15103320%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15103320%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

1146-1154

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15103320%20AND%20SRC:MED&resulttype=core&format=json

Human immunodeficiency virus type 1 subtypes differ in disease progression

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

21 January 2018

HIV vaccines 1983-2003.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

21 January 2018

HIV vaccine strategies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

Immunostimulatory CpG motifs trigger a T helper-1 immune response to human immunodeficiency virus type-1 (HIV-1) gp 160 envelope proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

Enhanced immune responses after DNA vaccination with combined envelope genes from different HIV-1 subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

gp120: Biologic aspects of structural features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

Gene inoculation generates immune responses against human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

Role of preimmunization virus sequences in cellular immunity in HIV-infected patients during HIV type 1 MN recombinant gp160 immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

CpG-DNA aided cross-presentation of soluble antigens by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

Induction of antigen-specific Th1-biased immune responses by plasmid DNA in schistosoma-infected mice with a preexistent dominant Th2 immune profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

Interactions of single and combined human immunodeficiency virus type 1 (HIV-1) DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

Mapping of B-cell epitopes in rabbits immunised with various gag antigens for the production of HIV-1 gag capture ELISA reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

HIV in Europe--a growing threat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

7 January 2021

Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

7 January 2021

Interleukin 7 can enhance antigen-specific cytotoxic-T-lymphocyte and/or Th2-type immune responses in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

7 January 2021

Rectal and vaginal immunization with a macromolecular multicomponent peptide vaccine candidate for HIV-1 infection induces HIV-specific protective immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

7 January 2021

Cytokine molecular adjuvants modulate immune responses induced by DNA vaccine constructs for HIV-1 and SIV

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

7 January 2021

Induction of immune responses and break of tolerance by DNA against the HIV-1 coreceptor CCR5 but no protection from SIVsm challenge

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

7 January 2021

A novel potent strategy for induction of immunity to HIV-1 reverse transcriptase in primates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

7 January 2021

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

7 January 2021

Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

7 January 2021

The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

7 January 2021

Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

7 January 2021

Immunodominant glycoprotein 41 epitope identified by seroreactivity in HIV type 1-infected individuals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302275

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302275

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15103320%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

27 December 2019

1006349426

0 references

1 reference